Literature DB >> 10511405

Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC.

N D Hanson1, K S Thomson, E S Moland, C C Sanders, G Berthold, R G Penn.   

Abstract

Organisms encoding multiple antibiotic resistance genes are becoming increasingly prevalent. In this report we describe a multiply resistant Klebsiella pneumoniae which possesses at least five different beta-lactamase genes. Isoelectric focusing, polymerase chain reaction and restriction fragment length polymorphism analysis identified TEM-1, multiple SHVs, OXA-9 and a plasmid-mediated ampC, beta-lactamase. Furthermore, Southern analysis and conjugation experiments established that most of the resistance genes were encoded on one large transferable plasmid. This report demonstrates the complexity of multiply resistant organisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10511405     DOI: 10.1093/jac/44.3.377

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.

Authors:  Maurine A Leverstein-van Hall; Ad C Fluit; Armand Paauw; Adrienne T A Box; Sylvain Brisse; Jan Verhoef
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

3.  Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five US States.

Authors:  E Smith Moland; J A Black; A Hossain; N D Hanson; K S Thomson; S Pottumarthy
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.

Authors:  Johann D D Pitout; Ashfaque Hossain; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

5.  Molecular analysis of the simultaneous production of two SHV-type extended-spectrum beta-lactamases in a clinical isolate of Enterobacter cloacae by using single-nucleotide polymorphism genotyping.

Authors:  Dóra Szabó; Melissa A Melan; Andrea M Hujer; Robert A Bonomo; Kristine M Hujer; Christopher R Bethel; Katalin Kristóf; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

6.  Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.

Authors:  Wonkeun Song; Ellen S Moland; Nancy D Hanson; James S Lewis; James H Jorgensen; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamases.

Authors:  Ellen Smith Moland; Seong Geun Hong; Kenneth S Thomson; Davise H Larone; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

8.  Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.

Authors:  Ying-Tsong Chen; Tsai-Ling Lauderdale; Tsai-Lien Liao; Yih-Ru Shiau; Hung-Yu Shu; Keh-Ming Wu; Jing-Jou Yan; Ih-Jen Su; Shih-Feng Tsai
Journal:  Antimicrob Agents Chemother       Date:  2007-05-25       Impact factor: 5.191

9.  Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases.

Authors:  Philip E Coudron; Nancy D Hanson; Michael W Climo
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt.

Authors:  Noha G Khalaf; Mona M Eletreby; Nancy D Hanson
Journal:  BMC Infect Dis       Date:  2009-06-04       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.